4
Changes in Ownership
Kairos Pharma, LTD. Filed Acc 0001493152-25-025197
CEO and Chairman acquired 190,840 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Yu John S · CEO and Chairman
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-08 | Grant or award : show line 1 in the form | +190,840 | 230,105 | D |
Loading xslF345X05/ownership.xml…